HeartSciences to Present at the 2022 RHK Disruptive Growth Conference on December 5, 2022
Southlake, Texas, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the...
Day: November 28, 2022
Clinical Trial Guide to Sponsor Webinar on Pediatric Clinical Trials
Clinical Trial Guide Pediatric-Clinical-Trials-WebinarIn a webinar sponsored by the new online resource, ClinicalTrialGuide.com, experienced clinical professionals will discuss the often-complicated...
Innovation Pharmaceuticals Announces BT BeaMedical Technologies Receives FDA Clearance for New Surgical Laser Family
Regulatory clearance lays key technological and regulatory foundation for BT BeaMedical’s vision of revolutionizing treatment options in neurosurgery, oncology, and...
Philips launches new compact ultrasound system at RSNA 2022, allowing first-time-right diagnosis for more patients
An ultrasound scan in progress November 28, 2022 New Ultrasound Compact System 5000 Series delivers premium image quality needed to...
Lumanity Announces Strategic Partnership with HealthVerity to Provide Streamlined Access to Real-World Data, World-Class Analytics, and Value Demonstration Expertise
Lumanity Announces Strategic Partnership with HealthVerity to Provide Streamlined Access to Real-World Data, World-Class Analytics, and Value Demonstration Expertise Lumanity’s...
Panbela Announces First Patients Enrolled in Europe for ASPIRE Trial Studying Ivospemin (SBP-101) in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
MINNEAPOLIS, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc . (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for...
Eye On Health Phoenix Offers New Expert Diabetic Eye Care Exams In Phoenix, Arizona
Phoenix, Arizona, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Eye on Health Phoenix was founded in 2013 by Dr. Balocca, an...
Privia Health to Participate in the Piper Sandler Healthcare Conference
ARLINGTON, Va., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that its management team...